Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Gorelick

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Lancet. Neurology|September 2, 2008
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled studyHans-Christoph Diener, Ralph L Sacco, Salim Yusuf, et al.
The New England Journal of Medicine|August 30, 2008
Telmisartan to prevent recurrent stroke and cardiovascular eventsSalim Yusuf, Hans-Christoph Diener, Ralph L Sacco, et al.
JAMA Neurology|September 16, 2025
Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia-The VasCog-2-WSO Criteria, Perminder S Sachdev, Adam C Bentvelzen, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Lancet. Neurology|September 2, 2008
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled studyHans-Christoph Diener, Ralph L Sacco, Salim Yusuf, et al.
The New England Journal of Medicine|August 30, 2008
Telmisartan to prevent recurrent stroke and cardiovascular eventsSalim Yusuf, Hans-Christoph Diener, Ralph L Sacco, et al.
JAMA Neurology|September 16, 2025
Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia-The VasCog-2-WSO Criteria, Perminder S Sachdev, Adam C Bentvelzen, et al.
Pageof 3